This story tells me that if we wish to change the world, we will all need to change individually. I feel it’s time to tell this tale, with its universal message of spiritual awakening.” Tigran ...
ResVita Bio, a synthetic biology company, announces that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the NIH has awarded the company a $2.03M Phase II Small ...
The scientists, working at the Department of Energy’s Oak Ridge National Laboratory, used neutrons at the Spallation Neutron Source and the High Flux Isotope Reactor to identify exact atomic-scale ...
Discover Sun Pharmaceutical's new patent for synthesizing D-serine-2-d, detailing innovative methods and versatile compounds for advanced pharmaceutical applications.
Discover Alnylam Pharmaceuticals' groundbreaking patent for RNAi agents targeting the Serpina1 gene, offering innovative treatments for liver disorders and beyond.
After RNAPII associates with the promoter, TFIIH is recruited, leading to phosphorylation of Serine 5 (inset) in the carboxyl terminal domain by the TFIIH-associated kinase Kin28 and initiation.